[Hemotherapy in malignant hematologic diseases].
For the majority of patients with malignant blood diseases the ideal transfusion products are blood components instead of whole blood. The therapeutic use of packed red cells, platelets, leukocytes and albumin is briefly discussed.
D000937:Antigen-Antibody Reactions; D001792:Blood Platelets; D001803:Blood Transfusion; D004912:Erythrocytes; D005340:Fibrinogen; D006649:Histocompatibility Antigens; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D007962:Leukocytes; D012709:Serum Albumin; D005719:gamma-Globulins
D006649:Histocompatibility Antigens; D012709:Serum Albumin; D005719:gamma-Globulins; D005340:Fibrinogen
Hämotherapie bei malignen Blutkrankheiten